MLB sues Biogeneis, Anthony Bosch, claims interference with contract

57 Comments

Major League Baseball has filed its lawsuit against Anthony Bosch and Biogenesis. There are multiple other defendants as well.* The claim: that by selling drugs to major league players, Biogenesis and Anthony Bosch “enabled such Players to possess and/or use [performance enhancing drugs] and thus knowingly and intentionally caused and/or induced such Players to breach their contractual obligations under MLB’s Joint Drug Prevention and Treatment Program not to possess or use [performance enhancing drugs].”

UPDATE: The entire complaint can be seen below.

This morning my primary legal criticism of the claims were that Major League Baseball could not show damages as a result of these acts. I have not changed my mind, if for no other reason than the contract MLB claims interference with is the Joint Drug Agreement, in which MLB has no direct financial interest. Indeed, it EXPECTS the JDA to be breached and has built in a punishment system because of it. When a player takes PEDs he violates it, by definition. Major League Baseball does not have a cause of action for breach of contract against them. How Major League Baseball expects to get greater satisfaction from an alleged third party tortfeasor than it could get from a party to the contract is … interesting.

That said, here are their damages allegations:

Due to Defendants’ actions, MLB has suffered damages, including the costs of investigation, loss of goodwill, loss of revenue and profits and injury to its reputation, image, strategic advantage and fan relationships.

Nothing surprising. But also nothing which seems at all to be the stuff of a meritorious lawsuit.  It’s loss of goodwill, outside of that involving a few columnists, is impossible to quantify. Its revenue and profits are at record highs and many would argue that these were achieved thanks in part to the PED-inflated offensive numbers of the past 20 years, not despite it.

This lawsuit is crazy on its face. It should be thrown out of court. I am shocked Major League Baseball found someone who would file it.

source:

source:

source:

source:

source:

source:

source:

source:

source:

source:

source:

source:

source:


source:

*The defendants:  BioGenesis of America, LLC, a Florida Limited Liability Company (“BioGenesis”); Biokem, LLC, a Florida Limited Liability Company (“Biokem”); Anthony P. Bosch (“Bosch”); Carlos Acevedo (“Acevedo”); Ricardo J. Martinez (“Martinez”); Juan Carlos Nunez (“Nunez”); Marcelo Albir (“Albir”); and Paulo da Silveira

Video: Jake Arrieta hits a 465-foot home run off of Zack Greinke

Jamie Squire/Getty Images
3 Comments

Jake Arrieta‘s bat is in midseason form already. The Cubs’ ace swatted a solo home run to center field off of Zack Greinke in Thursday afternoon’s Grapefruit League exhibition game, his first homer of the spring.

The blast went 465 feet, according to MLB.com’s Daren Willman.

Arrieta has hit two home runs in each of the past two seasons. Madison Bumgarner (eight) and Noah Syndergaard (four) are the only other pitchers to match or exceed his output in that department.

Greinke, meanwhile, is hoping to bounce back after a miserable 2016 season. He finished with an uncharacteristic 4.37 ERA in 26 starts in his first year with the Diamondbacks.

Luis Valbuena to miss four to six weeks with a strained right hamstring

Kent Horner/Getty Images
1 Comment

Angels first baseman Luis Valbuena will miss the next four to six weeks with a strained right hamstring, Pedro Moura of the Los Angeles Times reports.

Valbuena, 31, signed a two-year, $15 million contract with the Angels in January and was on track to get the lion’s share of the playing time at first base. While he’s out, however, C.J. Cron will handle first base on a regular basis. When Valbeuna returns, the two will likely form a platoon.

Last year with the Astros, Valbuena hit a solid .260/.357/.459 with 13 home runs and 40 RBI in 342 plate appearances.